CenterWatch Launches Service Linking Global Investigators with Clinical Research Sponsors

BOSTON--(BUSINESS WIRE)-- CenterWatch today announced a new service designed to assist biopharmaceutical companies and contract research organizations (CROs) in identifying and engaging investigative sites worldwide to conduct phase I through IV clinical trials.

Over the past several years, clinical research sponsors have become increasingly interested in recruiting skilled and active investigators from a larger and more diverse number of global regions. During this same period, the number of investigative sites exiting the clinical research enterprise has grown, as sites find it increasingly difficult to secure study grants. The new CenterWatch ‘Grant Notification Service’ is designed to match clinical research sponsors with currently active, experienced investigative sites and to provide an effective study grant generation tool for research professionals.

The service will be largely automated through the CenterWatch web site at www.centerwatch.com/trialwatch_signup and free of charge to use. By the end of September 2010, CenterWatch anticipates having 25,000 active global investigative sites registered on the service. In addition, CenterWatch anticipates handling three to five unique requests weekly from sponsor and CRO companies. Each specific request will generate a list of selected investigative sites to be contacted by the sponsor or CRO originating the request.

“We’re very pleased to be offering a new web-based service to the global investigative site community,” said Joan Chambers, CenterWatch Chief Operating Officer. “Our company has a long history of offering sites the opportunity to identify and secure study grants through our publications. We’re also excited to be providing sponsors and CROs with a quick and efficient way to identify and to ultimately contact viable investigative sites worldwide.”

For more information about this new Grant Notification Service or other CenterWatch publications and services, contact Tracy Lawton at 617-948-5132, [email protected], or visit www.centerwatch.com.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites; business development leads for contract service providers; postings of career opportunities; listings of clinical trials actively seeking patients; advertising and promotional opportunities; and proprietary business analysis and data about the global clinical trials industry. Visit www.centerwatch.com.



CONTACT:

CenterWatch
Cheryl Rosenfeld, 617-948-5172
Editor-in-Chief
[email protected]

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Clinical Trials  Medical Devices  Pharmaceutical  Other Health  Professional Services  Finance  Research  FDA  Science

MEDIA:

Logo
 Logo

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.